WashU Medicine to no longer participate in U.S. News & World Report rankings (Links to an external site)
Washington University School of Medicine in St. Louis announced that it will no longer submit data to U.S. News & World Report to support their “best medical schools” survey and ranking.
Brandon Tan, MD, selected as 2023 Dean’s Scholar
Brandon Tan, MD, PGY5 and an ASAP trainee, has been selected as one of the 2023 Dean’s Scholars. His project explores how the serotonin 3 receptor—implicated in nausea, depression, anxiety, and psychosis—changes its activity when the lipid environment is altered.
Burel R. Goodin, PhD, to join Department of Anesthesiology
The Department of Anesthesiology is delighted to announce that Burel R. Goodin, PhD, is joining Washington University School of Medicine as professor of anesthesiology March 1, 2023.
Introducing the SOCCA Service Chiefs’ Advisory Council (Links to an external site)
Vice Chair and Chief of Critical Care Medicine, Anne Drewry, MD, has been elected to serve as the vice chair for the SOCCA Service Chiefs’ Advisory Council.
Department celebrates CRNA Class of 2022
Goldfarb School of Nursing, including the nurse anesthesia program, celebrated its commencement ceremony on Saturday, December 17, 2022, at Powell Symphony Hall. Overall, nine graduates completed their nurse anesthesia education and received a Doctor of Nursing Practice—the first cohort to graduate with a doctoral degree. Congratulations to the entire Class of 2022 Nurse Anesthesia cohort!
Dr. Helga Komen appointed physician leader for POD 5
Dr. Helga Komen has accepted the role of an anesthesiology physician leader in POD 5 at Washington University in St. Louis School of Medicine.
WashU, pharmacy scientists alter fentanyl, aim to make it less lethal, less addictive (Links to an external site)
A research team, led by scientists at the Center for Clinical Pharmacology at Washington University School of Medicine and the University of Health Sciences & Pharmacy in St. Louis, have altered the chemical properties of fentanyl and the way that it binds to opioid receptors on nerve cells. The goal is to improve the drug’s safety profile without eliminating its ability to alleviate pain.
Majumdar Featured in Nature Chemical Biology (Links to an external site)
The paper highlights the work of Susruta Majumdar, Ph.D., associate professor of medicinal chemistry and pharmacology at University of Health Sciences and Pharmacy in St. Louis, and his colleagues who examined the molecular differences between LFT and MP, and how they bind to MU opioid receptors.